Market cap
$4 Mln
Revenue (TTM)
$3 Mln
P/E Ratio
--
P/B Ratio
117.4
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -19.89 | -- | -- | -- | -- |
| EBIT | 215.98 | 196.10 | -145.82 | 15.89 | 1.89 |
| Net Profit | 325.61 | 189.28 | 81.72 | 19.92 | 10.37 |
| EPS | 313.39 | 144.88 | 86.03 | 22.52 | 13.82 |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-23 | Dec-22 |
| EBIT-Margin
| -4,071.92 | -4,071.92 | -1,280.74 | -4,071.92 | -- |
| Net Margin
| -- | -- | -826.10 | -- | -- |
| Return on equity
| 53.03 | -14.08 | -- | 1,148.30 | -859.65 |
| Return on Capital
| -97.49 | -100.14 | -- | -71.61 | -140.59 |
| Return on Assets
| -76.37 | -69.72 | -14.65 | -55.51 | -112.86 |
| Debt to Equity (x)
| -- | -- | 0.00 | -28.13 | -12.96 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
--
|
-71.61
|
-140.59
|
-80.26
|
-103.59
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
--
|
1,148.30
|
-859.65
|
-129.55
|
-114.34
|
|
Peer Median
|
-33.19
|
--
|
--
|
--
|
--
|
ROA
-14.65
Higher than Peers by 27.65
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
-14.65
|
-55.51
|
-112.86
|
-60.75
|
-68.18
|
|
Peer Median
|
-42.29
|
--
|
--
|
--
|
--
|
EBIT Margin
-1,280.74
Lower than Peers by 1,243.76
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
-1,280.74
|
-4,071.92
|
--
|
--
|
--
|
|
Peer Median
|
-36.98
|
--
|
--
|
--
|
--
|
Net Margin
-826.10
Lower than Peers by 741.51
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
-826.10
|
-3,531.17
|
--
|
--
|
--
|
|
Peer Median
|
-84.60
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
-145.82
Lower than Peers by 159.35
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
-145.82
|
-196.87
|
186.03
|
-39.91
|
-29.13
|
|
Peer Median
|
13.53
|
--
|
--
|
--
|
--
|
Net Profit Growth
81.72
Higher than Peers by 72.58
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
81.72
|
59.19
|
-67.03
|
-20.89
|
-122.55
|
|
Peer Median
|
9.14
|
--
|
--
|
--
|
--
|
EPS Growth
86.03
Higher than Peers by 63.86
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
86.03
|
0.79
|
-0.33
|
-0.01
|
-0.33
|
|
Peer Median
|
22.17
|
--
|
--
|
--
|
--
|
Book Value Growth
38.73
Higher than Peers by 58.24
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
38.73
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-19.51
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
--
|
-28.13
|
-12.96
|
1.81
|
0.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-4.07
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
-4.07
|
-2.64
|
-0.33
|
0.06
|
0.03
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.35
Lower than Peers by 6.07
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
0.35
|
2.16
|
2.68
|
3.88
|
6.03
|
|
Peer Median
|
6.42
|
--
|
--
|
--
|
--
|
Quick Ratio
0.33
Lower than Peers by 6.09
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
0.33
|
2.09
|
2.68
|
--
|
--
|
|
Peer Median
|
6.42
|
--
|
--
|
--
|
--
|
Interest Coverage
0.19
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
0.19
|
-9.57
|
17.11
|
-33.19
|
-5.86
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
38.41
Higher than Peers by 10.58
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
38.41
|
90.25
|
--
|
--
|
--
|
|
Peer Median
|
27.82
|
--
|
--
|
--
|
--
|
Asset Turnover
0.02
Lower than Peers by 0.24
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
0.02
|
0.02
|
--
|
--
|
--
|
|
Peer Median
|
0.26
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
--
|
164.81
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
--
|
100.08
|
--
|
--
|
-891.13
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
--
|
433.93
|
6,083.07
|
6,186.79
|
3,833.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
--
|
-169.04
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
--
|
-0.94
|
-0.62
|
-1.63
|
-5.44
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
117.40
Higher than Peers by 112.46
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
117.40
|
-20.08
|
-11.99
|
3.43
|
4.21
|
|
Peer Median
|
4.94
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-0.71
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
-0.71
|
-1.27
|
-1.82
|
-1.55
|
-4.97
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
4
Lower than Peers by 20
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Gamida Cell - ADR
|
4
|
--
|
--
|
--
|
--
|
|
Peer Median
|
25
|
--
|
--
|
--
|
--
|